Insights into Company Bills & Payments

Aries Agro Limited

📍 Mumbai, Maharashtra, India Active NSE ARIES CIN L99999MH1969PLC014465 Agriculture & Agri-Inputs
Search companies

Key Metrics of Aries Agro Limited

Revenue₹702 Cr▲ 17.4% YoYFY 2025-26
EBITDA₹79.7 Cr▲ 18.6% YoY
Net profit₹38.4 Cr▲ 19.0% YoY
Net worth₹312 Cr▲ 13.7% YoY
Competitors10identified

About Aries Agro Limited

Sectors

Agriculture & Agri-InputsFertilisers, Seeds & Crop Protection

Company details

Registered office
Aries House, Plot No. 24, Deonar, Govandi-east, Mumbai, In-mh, 400043
Listed
NSE: ARIES · ₹496.65

Operational Areas of Aries Agro Limited

Agriculture & Agri-Inputs›Fertilisers, Seeds & Crop Protection

Company summary

Entity details

CINL99999MH1969PLC014465
LEI code335800K94AT6M1U7BR05
State codeMH
PIN code400043
Current legal nameARIES AGRO LIMITED
Classification—
Listing statusListed (NSE: ARIES)
Registration no.014465
Company age—
PAN—
CountryIndia
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueMGT-7 for FY 2025-26 · 29 Nov 2026

Industry classification

NIC code99999
Description of main activityExtra-territorial organisations and bodies
Description of business activityExtra-territorial organisations and bodies
SectorAgriculture & Agri-Inputs · Fertilisers, Seeds & Crop Protection

Share price · NSE: ARIES

ARIES on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date passed
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 24 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 12 Mar 2020 Withdrawn Stable outlook · Short term A3 · Withdrawn
Change in last 12 monthsNo change
Change since first rating on record▼ 2 notchessince Aug 2016
Rating actions50 up · 0 down

NoteLatest action: rating withdrawn (CARE, 12 Mar 2020)

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
12 Mar 2020CAREWithdrawn BBB-A3Stable₹175 Cr View
10 Jun 2019CARERevised BBB-—Stable₹350 Cr View
04 Oct 2018CAREReaffirmed BBB+A3+Stable₹175 Cr View
05 Jan 2018CAREReaffirmed BBB+A3+Stable₹176 Cr View
12 Aug 2016CAREAssigned BBB+A2—₹176 Cr View

Credit strengths (CARE, Mar 2020)

+ Established presence in micronutrient industry and experienced promoters

AAL commenced commercial operations in 1969 and has a successful track record of more than four decades in micronutrients industry. The company is founded and managed by Mirchandani family, holding 52.66% equity stake in AAL as on March 31, 2019. Dr. Rahul Mirchandani, Chairman and Managing Director, spearheads the overall operations of AAL having more than two decades of experience in agrochemical industry. Diversified product portfolio catering to all stages of agricultural activities

+ Diversified product portfolio catering to all stages of agricultural activities

The company manufactures and trades in wide range of products expanded over the years which include chelated micronutrients, specialty fertilizers, secondary nutrients and water soluble fertilizers, and currently, owns more than 65 brands. The product portfolio finds application at various stages of farming including application of nutrients during soil preparation, multi-stage usage of nutrients/fertilizers during the entire crop cycle (2-3 applications), and crop protection

+ Wide spread distribution network through established relationship with distributors

The company’s strong distributorship emanates from strong network of more than 1,250 dealers, 7,000 distributors and 70,000 retailers making AAL’s products available across 2, 00,000 villages in India.

Credit challenges

− Working capital intensive nature of operations with elongated operating cycle

AAL sells its products to dealers/distributors who in turn offer credit period to the farmers as per the crop cycle, thus leading to high receivable days. On account of seasonality in sales and to ensure product loyalty, AAL holds a huge stock of inventory thus leading to high inventory days. Thus, AAL’s operations are working capital intensive as is evident from operating cycle 1 Complete definition of the ratings assigned are available at www.careratings.com and other CARE publications

− Delay in collection of receivables from UAE based subsidiary despite stake sale

AAL has two subsidiaries in UAE namely Golden Harvest Middle East FZC (GHM) and Amarak Chemicals FZC (Amarak). Operations in GHM ceased in FY16 due to change in duty structure. Operations in Amarak (step-down subsidiary of GHM), were disrupted in FY18 (no operations till December 2019) on account of challenges in sourcing of major raw material i.e. sulphur and on the lack of availability of power. An amount of Rs. 86.57 Crore (as on March 31, 2019) is outstanding as

− Modest Scale of Operations with operating profit margin susceptible to raw material and foreign exchange rates

AAL reported a Total Operating Income of Rs. 268.61 Crore in FY19 (decline of 8% in comparison to the previous year). The decline is mainly attributed to rainfall deficit and dampened farmer sentiment. AAL’s operations are highly dependent on agricultural activity in the country and thus directly linked to monsoon and climatic conditions. As is evident from the TOI, AAL’s scale of operations is modest. CARE notes that in 9MFY20 operating income has grown by 15% on a yoy basis although,

− Moderation in gearing levels; albeit weakening of debt coverage for FY19

The debt composition of AAL mainly consists of working capital borrowings which is used to fund its operating cycle. Overall gearing stood at 0.81 times as on March 31, 2019 (0.93 times in March 31, 2018). The debt coverage indicators like Total Debt to GCA and Interest Coverage weakened during FY19 on account of high finance cost on back of persistently high debt coupled with lower cash accruals. Inherent risk of the industry along with intense competition

− Inherent risk of the industry along with intense competition

The industry derives sales from the agriculture sector which is highly dependent upon monsoons as well as fungal/pest attack on crops. One of the other major restraints to growth of the agriculture micronutrients market is the lack of awareness among farmers in developing countries regarding appropriate dosage and proper application of micronutrients, thereby limiting its demand. The company faces stiff competition from unorganized players in the market. The industry is

Agency-reported financials (CARE, 12 Mar 2020)

Metric9MFY20
Total Operating Income₹246 Cr
PBILDT₹47.13 Cr
PAT₹14.13 Cr
Overall Gearing (times) 0.80 0.93 0.81 Not available0.81×
Interest coverage (times)2.57×
EBITDA margin19.2%
Implied interest cost (EBITDA ÷ coverage)₹18.34 Cr
PAT margin5.7%

Borrowings & rated debt

Rated borrowing limits (latest)₹350 Cr
Peak rated limits₹350 CrJun 2019 · CARE
Limits raised0 times2 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Facilities Action Long-term Bank FacilitiesWorking capital & bank lines—₹127 Cr— BBB- (Stable)RevisedCARE
) Short-term Bank FacilitiesWorking capital & bank lines—₹48.5 Cr— —RevisedCARE
Total (Rupees One hundred Seventy Five crore Five lakhs only)Other—₹175 Cr— —OtherCARE

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
BG/LC—Withdrawn
Cash Credit—Withdrawn

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequate
DirectionStableAgency outlook: Stable
CARE rating · Jun 2019BBB-8 notches below indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
WithdrawalCARE · 12 Mar 2020 · Withdrawn at company request with lender NOCs
Next action stable or better (model)57%
Information on file67% · missing: Capex / investment plans, Auditor details, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 55% (At risk of downgrade) · ML model on 6893 rating histories, AUC 0.653
Rated limits₹350 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage—
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 55% chance the next rating action is stable or better
  • Current rating BBB- (investment grade)
  • CARE withdrew its ratings on 12 Mar 2020 — usually after the rated bank loans were repaid or moved to another lender

Rated limits by facility

Timeline

12 Mar 2020 CARE withdrawn: BBB- (Stable)Rated limits ₹175.05 cr CARE rationale
10 Jun 2019 CARE revised: BBB- (Stable)Rated limits ₹350.1 cr CARE rationale
10 Jun 2019 Cash & liquid funds ₹9.2 cr
From the report

AAL reported gross cash accruals of Rs. 9.20 Crore for FY19 as against the Rs.11.35 crore for FY18.

CARE rationale
04 Oct 2018 CARE reaffirmed: BBB+ (Stable)Rated limits ₹175.05 cr CARE rationale
04 Oct 2018 New borrowing arranged (term loans)
From the report

Moderate capital structure 1 Complete definition of the ratings assigned are available at www.careratings.com and other CARE publications 1 CARE Ratings Limited Press Release The company’s total debt majorly comprises of working capital bank borrowings followed by term availed to fund capital expenditure, and others.

CARE rationale
04 Oct 2018 New borrowing arranged (term loans)
From the report

Analytical approach: CARE analysed AAL’s credit profile by considering consolidated financial statements of the company owing to financial and operational linkages between the parent and subsidiaries, common management, fungible cash flows, and facility availed by AAL for funding working capital requirement in subsidiaries. 2 CARE Ratings Limited Press Release Applicable Criteria Criteria on assigning Outlook to Credit Ratings CARE’s Policy on Default Recognition CARE’s methodology for Short-term Instruments CARE’s methodology for manufacturing companies Financial ratios – Non-Financial Sector

CARE rationale
05 Jan 2018 CARE reaffirmed: BBB+ (Stable)Rated limits ₹176 cr CARE rationale
05 Jan 2018 Average working-capital utilisation 89%
From the report

The average utilization of working capital banks limits for the 12 months ending October 2017 is high at 89% providing limited liquidity back-up.

CARE rationale
05 Jan 2018 New borrowing arranged (term loans)
From the report

Analytical approach: CARE analysed AAL’s credit profile by considering consolidated financial statements of the company owing to financial and operational linkages between the parent and subsidiaries, common management, fungible cash flows, and facility availed by AAL for funding working capital requirement in subsidiaries.

CARE rationale
12 Aug 2016 CARE assigned: BBB+Rated limits ₹176 cr CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeARIES HOUSE, PLOT NO. 24, DEONAR, GOVANDI-EAST, MUMBAI, IN-MH, 400043
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Aries Agro Limited

Competitors10identified
Locations2most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Mahindra and Mahindra Manufacturing · Automobile and Tractor Manufacturing mahindra.com 1945 Mumbai, India
UPL Fertilisers, Seeds & Crop Protection · Agriculture & Agri-Inputs upl-ltd.com — Vapi, India
Coromandel International Discovered Companies · Other Industries coromandel.biz — Hyderabad, India
National Fertilizers Limited Fertilisers, Seeds & Crop Protection · Agriculture & Agri-Inputs nationalfertilizers.com — New Delhi, India
Rashtriya Chemicals and Fertilizers Fertilisers, Seeds & Crop Protection · Agriculture & Agri-Inputs rcfltd.com 1956 Mumbai, India
Chambal Fertilisers and Chemicals Fertilisers, Seeds & Crop Protection · Agriculture & Agri-Inputs chambalfertilisers.com — Kota, India
Gujarat Narmada Valley Fertilizers & Chemicals Limited Fertilisers, Seeds & Crop Protection · Agriculture & Agri-Inputs — — Bharuch, India
Jain Irrigation Systems Limited Part of Jain Irrigation Systems Limited. jains.com 1989 Jalgaon, India
PI Industries Fertilisers, Seeds & Crop Protection · Agriculture & Agri-Inputs piindustries.com — Udaipur, India
Hma Agro Industries Limited · Business Services — — Agra, Uttar Pradesh, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.